World's first confirmed Coronavirus re-infection reported in Hong Kong

▴ worlds-first-confirmed-coronavirus-reinfection-reported-hong-kong
The 33-year-old's second SARS-CoV-2 infection was detected via airport screening on his return to Hong Kong from Europe this month.

A man got the coronavirus in the wake of recouping from an underlying session in April in what researchers said was the main case demonstrating that reinfection may happen inside a couple of months.

The 33-year-old's second SARS-CoV-2 disease was recognized through air terminal screening on his arrival to Hong Kong from Europe this month. Scientists at the University of Hong Kong utilized genomic grouping examination to demonstrate that he was tainted by two unique strains. The data innovation laborer didn't build up any side effects from his subsequent contamination, which may specify "resulting diseases might be milder," the scientists said.

"Our discoveries propose that SARS-CoV-2 may continue in people," Kwok-Yung Yuen and associates said Monday in a paper acknowledged for distribution in the diary Clinical Infectious Diseases. The discoveries additionally propose SARS-CoV-2 is suggestive of the coronaviruses that cause the basic cold and may keep on coursing "regardless of whether patients have obtained resistance through regular disease or using immunization," they said.

While a few patients have tried positive for the infection over numerous weeks, significantly after their manifestations have settled, researchers haven't completely comprehended whether these cases reflect waiting hints of the infection, a re-ejection of a disease, or another contamination.

World-First

This is "the world's first documentation of a patient who recouped from Covid-19, yet got another scene of Covid-19 a short time later," the analysts said in a messaged explanation.

It might be hard to track down Covid-19 survivors who have been reinfected with SARS-CoV-2 on the off chance that they don't show side effects, said Corey Smith, head of translational and human immunology at the QIMR Berghofer Medical Research Institute in Brisbane.

"Since he demonstrated no side effects on the subsequent contamination, almost certainly, even though the infection has figured out how to build up contamination, his memory safe reaction has likely forestalled any indicative ailment," Smith said in an email. "This recommends regular contamination may give security against sickness, however not reinfection."

Still Infectious?

One issue is that a reinfected individual may even now spread the SARS-CoV-2 infection to somebody who hasn't been recently uncovered, he said.

It's unavoidable that reinfections will happen, said Thomas File, leader of the Infectious Diseases Society of America and seat of irresistible maladies at Summa Health, an emergency clinic framework in Akron, Ohio. "The inquiry is how long after the underlying contamination may that happen?"

Assurance from reinfection will shift among individuals and may rely upon the individual patient, their insusceptible framework, regardless of whether the patient created indications to the primary contamination, and the idea of the second infection to which they have been uncovered, File said in a meeting Monday.

"We realize that if you take a gander at the occasional endemic coronaviruses, the measure of insusceptibility can be as low as four, five or a half year to possibly as long as a year or two," he said.

Questions Remain

Around the world, about 24 million individuals are known to have been contaminated with Covid-19, Maria Van Kerkhove, the World Health Organization's specialized lead on Covid-19, told columnists in Geneva Monday. Most patients - even the individuals who have a gentle case - mount a safe reaction to the contamination, she said.

It's important to document cases like the one described in Hong Kong, "but not jump to any conclusions," Van Kerkhove said. Studies tracking larger numbers of cases over time are needed to better understand the quality and durability of recovered patients' neutralizing antibody response to SARS-CoV-2, she said.

Tags : #Vaccine #Worldsfirst #COVID-19 #Hongkong

Related Stories

12 Nov

Sanofi completes acquisition of Kadmon

Latest pharma news updates

View
20 Sep

Sanofi completes acquisition of Translate Bio, accelerating the application of mRNA in new vaccines and therapeutics

Latest pharma news update

View
05 Aug

Sanofi to acquire Translate Bio; advances deployment of mRNA technology across vaccines and therapeutics

Corporate Pharma news upedat

View
17 Jul

LabGenius announces research collaboration with Ablynx, a Sanofi Company

Latest pharma update : Research and Collaboration

View
16 Jul

Sanofi extends collaboration with Genedata for Pharmaceutical Development & Manufacturing Science

Latest FDA approvals update

View
14 Jul

Sanofi streamlines Consumer Healthcare portfolio in Latin America with divestiture of eight brands to Hypera Pharma

As discussed during our Capital Markets Day in February, simplifying the CHC product portfolio is an important part of our strategy to focus our resources and efforts where we can bring the most value, especially to consumers.

View
09 Jul

Sanofi, GSK get approval for Phase 3 COVID-19 vaccine trial in India

In a two-stage approach, the study will initially investigate the efficacy of a vaccine formulation targeting the original virus strain (D.614), while a second stage will evaluate a second formulation targeting the Beta variant (B.1.351)

View
28 Apr

Moderna announces agreement with Sanofi for manufacturing of the Moderna COVID-19 Vaccine in the U.S.

Moderna and Sanofi collaborate for covid vaccine manufacturing

View
18 Mar

ProBioGen licenses GlymaxX Technology to Sanofi

GlymaxX enables a boost of antibody-dependent cell-mediated cytotoxicity (ADCC)

View
15 Feb

Sanofi's mRNA vaccine would not be available this year ; CEO

It could be of use at a later stage all the more if the fight against variants was to continue, said the CEO

View

-Advertisements-




Trending Now

Maternal and Infant Health in Focus as India Observes World Health Day 2025April 05, 2025
Under 15 Children Under Threat: The TB Comeback No One Saw Coming April 04, 2025
MGM Healthcare Performs World's First Modified Multi-Visceral Transplant for Rare Intestinal DisorderApril 04, 2025
World Health Day 2025: St. George’s University’s Role in Preparing Doctors to Tackle Global Health ChallengesApril 04, 2025
Strength Doesn’t Retire: The Science Behind Ageless PowerApril 04, 2025
Beyond the Baby Bump: Can Delayed Pregnancy Increase Autism Risk in ChildrenApril 04, 2025
University of Manchester invites applications for MA Social AnthropologyApril 03, 2025
Ahead of World Health Day, Sova Health Launches Advanced Microbiome Tests & Evidence-Based Precision Supplements April 03, 2025
Half of women cannot make decisions about their reproductive health and bodily autonomyApril 03, 2025
UGRO CAPITAL LIMITED PUBLIC ISSUE OF SECURED, RATED, LISTED, REDEEMABLE, NON-CONVERTIBLE DEBENTURES (SECURED NCDS) OPENS TODAY EFFECTIVE ANNUALIZED YIELD UP TO 11.01% PER ANNUM* April 03, 2025
SF Airlines Entrusts Çelebi India with Freighter Handling at Kempegowda International Airport, BengaluruApril 03, 2025
Is This the Future of Physiotherapy? Inside Stance Health’s $1M ExpansionApril 03, 2025
The Daily Shower Debate: Are You Washing Away Your Skin’s Health?April 03, 2025
The Digital Sleep Thief: How Night-time Screen Addiction is Robbing You of Bed-time RestApril 02, 2025
KKR Launches ‘Knight Bite’ – A Digital Series That Serves Up Food, Fun, and Cricket!April 02, 2025
Crompton rolls out its all new range of Aura, Avancer & Jedi Air Coolers for an effortless summer cooling experienceApril 02, 2025
CARE Hospitals, Hi-Tech City Strengthens Orthopaedics Department with Renowned SurgeonsApril 02, 2025
World Autism Awareness Day: Breaking the Chains of Stigma in IndiaApril 02, 2025
From Scroll to Squint: How Reels Are Reshaping Your VisionApril 02, 2025
Moscow Center for Diagnostics and Telemedicine Receives License for Radiology Residency ProgramApril 02, 2025